Development

Zero-shot design produces multifunctional antibodies in six weeks

development2026-06-24

Claim

Nabla Bio's JAM-2 pushed zero-shot drug design beyond binding into multifunctional antibodies, including KRAS-targeting multispecifics built and tested in roughly six weeks, while Eli Lilly built an app store for scientists on its own Blackwell cluster.

Reported metric: ~6 weeks

Reporting date: 2026-06-24 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to June 24, 2026 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to June 24, 2026

Actor

Evidence for

Supersedes

Vaccination cuts cervical-cancer death before thirty to effectively zero

Referenced by

Cite or correct this record

Citation formatCitation text

Zero-shot design produces multifunctional antibodies in six weeks
Innermost Loop KB — secondary record
Reporting date: 2026-06-24
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-06-24-antibodies-designed-and-tested-in-six-weeks
Claim: Nabla Bio's JAM-2 pushed zero-shot drug design beyond binding into multifunctional antibodies, including KRAS-targeting multispecifics built and tested in roughly six weeks, while Eli Lilly built an app store for scientists on its own Blackwell cluster.
Attributed sources:
- Welcome to June 24, 2026 — https://theinnermostloop.substack.com/p/welcome-to-june-24-2026
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.